Lophora, a pioneering clinical-stage CNS drug discovery company founded in 2018, is thrilled to announce the successful raising of $3 million in funding to advance its innovative pipeline of next-generation psychedelic medicines designed to treat a range of psychiatric disorders. This significant investment comes from a combination of public sources and seasoned biotech investors, reflecting an increasing confidence in Lophora鈥檚 approach to mental health therapies. The funding will enable the company to kickstart its first-in-human trials for its lead candidate, LPH-5, with initial trials set to begin in 2024. LPH-5's efficacy has been comprehensively characterized through extensive in vivo studies and has successfully completed GLP-Tox, paving the way for anticipated Clinical Trial Application (CTA) submission by Q2 2024. Lophora is dedicated to transforming the landscape of psychiatric treatment through its cutting-edge research, driven by a commitment to addressing the pressing mental health needs of millions. With this new capital injection, Lophora is well-positioned to further advance its groundbreaking work, ultimately aiming to provide new hope for individuals seeking effective solutions for their mental health struggles. As the company forges ahead, it remains steadfast in its mission to develop safe, effective, and accessible therapies that have the potential to reshape psychiatric treatment for the better. For more information on Lophora and its initiatives, visit www.lophora.com.
Lophora Secures $3 Million in Funding for Groundbreaking Psychedelic Medicine Development
Recently funded 路 $3.0MPharmaceuticals
Get the full Lophora company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
